Zota Health Care LImited Asset Resilience Ratio

Latest as of March 2025: 0.68%

Zota Health Care LImited asset resilience ratio. Zota Health Care LImited (ZOTA) has an Asset Resilience Ratio of 0.68% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Zota Health Care LImited to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs29.74 Million
≈ $321.63K USD Cash + Short-term Investments

Total Assets

Rs4.39 Billion
≈ $47.49 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Zota Health Care LImited (2016–2025)

Asset resilience ratio of Zota Health Care LImited from 2016 to 2025. This chart shows how Zota Health Care LImited's Asset Resilience Ratio has changed over time. Read ZOTA total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Zota Health Care LImited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ZOTA asset base.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs14.87 Million 0.34%
Short-term Investments Rs14.87 Million 0.34%
Total Liquid Assets Rs29.74 Million 0.68%

Asset Resilience Insights

  • Limited Liquidity: Zota Health Care LImited maintains only 0.68% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company maintains a balanced mix of cash and short-term investments.

Zota Health Care LImited Industry Peers by Asset Resilience Ratio

Compare Zota Health Care LImited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Biotechnology 62.31%
Verona Pharma plc
F:I9SA
Biotechnology 0.00%
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA
Biotechnology 33.37%
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
Biotechnology 2.03%
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
Biotechnology 8.08%
Bavarian Nordic
CO:BAVA
Biotechnology 10.83%
Hebei Changshan Biochem Pharma
SHE:300255
Biotechnology -0.03%
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287
Biotechnology 37.31%

Zota Health Care LImited Asset Resilience Ratio by Year (2016–2025)

Zota Health Care LImited asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Zota Health Care LImited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 0.68% Rs29.74 Million
≈ $321.63K
Rs4.39 Billion
≈ $47.49 Million
+0.39pp
2024-03-31 0.29% Rs6.56 Million
≈ $70.94K
Rs2.28 Billion
≈ $24.69 Million
-1.01pp
2023-03-31 1.29% Rs20.46 Million
≈ $221.29K
Rs1.58 Billion
≈ $17.10 Million
-1.96pp
2022-03-31 3.25% Rs45.22 Million
≈ $489.02K
Rs1.39 Billion
≈ $15.04 Million
+0.16pp
2021-03-31 3.09% Rs26.39 Million
≈ $285.35K
Rs854.69 Million
≈ $9.24 Million
+1.26pp
2020-03-31 1.83% Rs16.21 Million
≈ $175.29K
Rs884.79 Million
≈ $9.57 Million
+1.83pp
2019-03-31 0.00% Rs120.00
≈ $1.30
Rs896.07 Million
≈ $9.69 Million
+0.22pp
2018-03-31 -0.22% Rs-2.00 Million
≈ $-21.63K
Rs917.94 Million
≈ $9.93 Million
+0.03pp
2016-03-31 -0.24% Rs-1.08 Million
≈ $-11.63K
Rs440.52 Million
≈ $4.76 Million
--
pp = percentage points

About Zota Health Care LImited

NSE:ZOTA India Biotechnology
Market Cap
$399.52 Million
Rs36.94 Billion INR
Market Cap Rank
#13099 Global
#656 in India
Share Price
Rs1217.90
Change (1 day)
-1.16%
52-Week Range
Rs1028.10 - Rs1687.00
All Time High
Rs1687.00
About

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores u… Read more